Overall, these data indicate that the ILC2s from the PB, but not from the BM, of MM pts retained cytolytic ability against MM cells, which is mediated by DNAM-1-engagement and subsequent GZMB release. The gene discussed is CD226; the disease is Miyoshi myopathy.